4.2 Hemoglobinopathies (Sickle Cell & Thalassemia), Anemias & Hematologic Malignancies

Hemoglobinopathies in Saudi Arabia

Hemoglobinopathies, particularly Sickle Cell Disease (SCD) and Thalassemia syndromes, are among the most common and morbid genetic disorders in Saudi Arabia. They display exceptionally high prevalence rates in the Eastern (e.g., Qatif, Al-Ahsa) and Southern (e.g., Jazan) provinces. Recognizing the immense public health burden, the Saudi government instituted a mandatory Premarital Screening Program to identify carriers, provide genetic counseling, and ultimately reduce the incidence of these autosomal recessive disorders.

Sickle Cell Disease (SCD) SCD is caused by a specific point mutation in the beta-globin gene (glutamic acid is replaced by valine at the 6th position), producing abnormal Hemoglobin S (HbS). Under conditions of hypoxia, acidosis, infection, or dehydration, HbS molecules polymerize, causing the red blood cells to distort into a sickled shape. This leads to rigid cells that cause microvascular occlusion, subsequent tissue ischemia, and chronic hemolytic anemia.

Clinical Manifestations:

• Vaso-Occlusive Crisis (VOC): The most common presentation, characterized by severe, sudden-onset ischemic pain in the bones and muscles (often in the back, chest, and long bones). Dactylitis (painful swelling of the hands and feet, known as hand-foot syndrome) is frequently the very first manifestation seen in infants.
• Acute Chest Syndrome (ACS): A leading cause of mortality in SCD, presenting with fever, severe chest pain, tachypnea, hypoxemia, and new pulmonary infiltrates on chest X-ray. It can be triggered by pulmonary fat embolism from infarcted bone marrow, infectious pneumonia, or direct pulmonary infarction.
• Splenic Sequestration: Characterized by rapid, massive pooling of blood in the spleen, leading to acute splenomegaly, profound rapidly worsening anemia, and potentially fatal hypovolemic shock. Over time, repeated splenic infarctions lead to functional autosplenectomy, typically complete by early childhood.
• Infection Risk: Autosplenectomy severely impairs the body's immunity against encapsulated organisms. Patients are at exceptionally high risk for sepsis and meningitis from Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis, as well as osteomyelitis uniquely caused by Salmonella species.

Management: Acute VOC requires rapid and aggressive hydration, adequate and scheduled analgesia (often requiring parenteral opioids), and supplemental oxygen if the patient is hypoxemic. ACS is a medical emergency requiring broad-spectrum antibiotics, bronchodilators, and often simple or exchange red blood cell transfusions to rapidly lower the HbS percentage. Long-term, disease-modifying management heavily relies on Hydroxyurea. This agent increases the production of fetal hemoglobin (HbF), which prevents HbS polymerization and significantly reduces the frequency of painful crises. Routine, scheduled vaccinations against encapsulated bacteria and prophylactic daily penicillin in children up to age 5 are strictly mandatory.

Thalassemia Syndromes Thalassemias are quantitative defects in globin chain synthesis, in contrast to the qualitative defect seen in SCD. Beta-thalassemia major (Cooley's anemia) involves the complete absence of beta-globin production, leading to severe microcytic anemia, ineffective erythropoiesis in the marrow, and massive extramedullary hematopoiesis.

Clinical Features and Management: Patients typically present in early infancy (as protective HbF levels naturally decline) with failure to thrive, massive hepatosplenomegaly, and classic skeletal deformities caused by severe marrow expansion ("chipmunk facies" and the classic "hair-on-end" appearance on skull X-ray). Management hinges on lifelong regular blood transfusions to adequately suppress the massive, ineffective erythropoiesis. However, this invariably leads to secondary hemochromatosis (iron overload). Iron deposition in the myocardium causes restrictive cardiomyopathy (the leading cause of death), while endocrine deposition causes diabetes, hypothyroidism, and hypogonadism. Aggressive iron chelation therapy (e.g., subcutaneous Deferoxamine or oral Deferasirox) is absolutely essential for long-term survival.

Systematic Approach to Anemia

Anemia is most practically classified based on the Mean Corpuscular Volume (MCV):

Microcytic Anemias (MCV < 80 fL):

• Iron Deficiency Anemia (IDA): The most common cause of anemia globally. It is caused by chronic blood loss (e.g., heavy menses, GI malignancy, hookworm), malabsorption (e.g., Celiac disease), or severe dietary deficiency. Lab profile: Low serum iron, uniquely low ferritin (the best initial and most specific test), and high Total Iron Binding Capacity (TIBC). The peripheral smear shows microcytic, hypochromic cells with significant anisocytosis (high RDW). In any adult male or post-menopausal female, occult GI bleeding must be definitively excluded via bidirectional endoscopy.
• Anemia of Chronic Disease (ACD): Driven by chronic inflammation, which increases hepatic hepcidin production. Hepcidin traps iron within macrophages, rendering it unavailable for erythropoiesis. Lab profile: Low serum iron, normal or high ferritin, and low TIBC.
• Thalassemia Trait: Presents as a mild anemia with a disproportionately very low MCV and a normal RDW. Lab profile shows normal or high iron and ferritin. Diagnosed definitively via hemoglobin electrophoresis (showing elevated HbA2 in beta-thalassemia trait).

Normocytic Anemias (MCV 80-100 fL): Often broadly divided into non-hemolytic (e.g., chronic kidney disease due to low EPO production, aplastic anemia causing pancytopenia) or hemolytic causes (e.g., G6PD deficiency, autoimmune hemolytic anemia, paroxysmal nocturnal hemoglobinuria). Intravascular hemolysis is strongly suggested by an elevated reticulocyte count, high LDH, high indirect bilirubin, and critically low haptoglobin.

Macrocytic Anemias (MCV > 100 fL):

• Megaloblastic: Caused by impaired DNA synthesis. Vitamin B12 deficiency (often due to pernicious anemia; presents with subacute combined degeneration of the spinal cord and hypersegmented neutrophils) and Folate deficiency (no neurological symptoms). Both feature elevated homocysteine, but only B12 deficiency has uniquely elevated methylmalonic acid (MMA).
• Non-megaloblastic: Common causes include chronic alcoholism, advanced liver disease, and severe hypothyroidism.

Hematologic Malignancies

Leukemias

• Acute Lymphoblastic Leukemia (ALL): The most common childhood malignancy. Presents acutely with bone pain, fever, bleeding, and diffuse lymphadenopathy. The peripheral smear shows lymphoblasts that are characteristically TdT positive.
• Acute Myeloid Leukemia (AML): Primarily affects older adults. The smear reveals myeloblasts containing pathognomonic Auer rods. A highly tested variant is Acute Promyelocytic Leukemia (APL, M3 variant), associated with the t(15;17) translocation. APL frequently presents with severe, life-threatening Disseminated Intravascular Coagulation (DIC) and uniquely responds to All-Trans Retinoic Acid (ATRA), which induces the malignant blasts to differentiate into mature cells.
• Chronic Myeloid Leukemia (CML): A myeloproliferative disorder driven by the Philadelphia chromosome t(9;22), creating the constitutively active BCR-ABL fusion tyrosine kinase. Presents with massive splenomegaly and marked leukocytosis representing the full myeloid spectrum. It is treated dramatically well with targeted tyrosine kinase inhibitors (e.g., Imatinib).
• Chronic Lymphocytic Leukemia (CLL): The most common adult leukemia in Western countries. Often entirely asymptomatic and diagnosed incidentally on routine blood work. The peripheral smear shows characteristic fragile "smudge cells."

Multiple Myeloma A malignant plasma cell dyscrasia characterized by the unchecked, monoclonal proliferation of plasma cells within the bone marrow. These cells secrete copious amounts of non-functional monoclonal immunoglobulins (usually IgG or IgA). It typically affects older adults.

Diagnostic Criteria (The CRAB Criteria):

• Calcium: Hypercalcemia (resulting from severe, osteoclast-mediated bone destruction).
• Renal failure: Light chain cast nephropathy (Bence Jones proteins damaging the tubules).
• Anemia: Normocytic anemia due to direct marrow infiltration by plasma cells.
• Bone lesions: Lytic "punched-out" bone lesions visible on X-ray, causing severe bone pain (especially in the back and ribs) and pathologic fractures.

Diagnosis involves Serum Protein Electrophoresis (SPEP) demonstrating a distinct M-spike (monoclonal protein), urine electrophoresis to detect Bence Jones proteins, and a definitive bone marrow biopsy showing >10% clonal plasma cells.